HALO logo
halo search icon
Roivant Sciences Ltd.
Roivant Sciences Ltd.
ROIV · NAS

Roivant Sciences Ltd.

US$30.88

Price Arrow-1.53 (-4.721%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Price MomentumHammer Bearish (Realtime)Volume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Roivant Sciences Ltd. Overview

ROIV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ROIV

icon

Website

Roivant Sciences Ltd.

icon

Telephone

icon

Address

Description

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

ROIV Price Chart

Key Stats

Market Cap

US$23.20B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 10.59 - 32.79

Trade Value (12mth)

US$33,209,082.00

1 week

10.65%

1 month

11.18%

YTD

47.79%

1 year

196.25%

All time high

32.79

Key Fundamentals

EPS 3 yr Growth

-109.70%

EBITDA Margin

NaN%

Operating Cashflow

-$750m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-425.30

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

812m

HALO Sector

Other Finance

Next Company Report Date

30-Jun-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ROIV Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
20 May 26
20 May 26
20 May 26

ROIV Fundamentals

Per Share Records

Historical data

Forecast data

USD2022202320242025202420252026202720282029
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.24N/A-0.54locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.24N/AN/Alocklocklock
Growth
%locklocklocklock-104.3N/AN/Alocklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Roivant Sciences Ltd. (ROIV:NAS)?
Halo FAQ
The current share price of Roivant Sciences Ltd. (ROIV:NAS) is USD$30.88.
What is the 52-week high share price for Roivant Sciences Ltd. (ROIV:NAS)?
Halo FAQ
The 52-week high share price for Roivant Sciences Ltd. (ROIV:NAS) is USD$32.79.
What is the 52-week low share price for Roivant Sciences Ltd. (ROIV:NAS)?
Halo FAQ
The 52-week low share price for Roivant Sciences Ltd. (ROIV:NAS) is USD$10.59.
What is the dividend yield for Roivant Sciences Ltd. (ROIV:NAS)?
Halo FAQ
Roivant Sciences Ltd. (ROIV:NAS) does not pay a dividend.
What was Roivant Sciences Ltd. (ROIV:NAS) last dividend payment?
Halo FAQ
Roivant Sciences Ltd. (ROIV:NAS) does not pay a dividend.
What is the franking level for Roivant Sciences Ltd. (ROIV:NAS)?
Halo FAQ
Roivant Sciences Ltd. (ROIV:NAS) has a franking level of 0.00%.
In which sector is Roivant Sciences Ltd. (ROIV:NAS) classified?
Halo FAQ
Roivant Sciences Ltd. (ROIV:NAS) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.